P. Storz, Reactive oxygen species in tumor progression, Front Biosci, vol.10, pp.1881-96, 2005.

G. Waris and H. Ahsan, Reactive oxygen species: role in the development of cancer and various chronic conditions, J Carcinog, vol.5, p.14, 2006.

K. Block and Y. Gorin, Aiding and abetting roles of NOX oxidases in cellular transformation, Nat Rev Cancer, vol.12, pp.627-664, 2012.

U. Weyemi, C. E. Redon, P. R. Parekh, C. Dupuy, and W. M. Bonner, NADPH oxidases NOXs and DUPXs as putative targets for cancer therapy, Anticancer Agents Med Chem, vol.13, pp.502-516, 2013.

K. Brieger, S. Schiavone, F. J. Miller, and K. H. Krause, Reactive oxygen species: from health to disease, Swiss Med Wkly, vol.142, p.13659, 2012.

M. Benhar, D. Engelberg, and A. Levitzki, ROS, stress-activated kinases and stress signaling in cancer, EMBO Rep, vol.3, pp.420-425, 2002.

L. Tochhawng, S. Deng, S. Pervaiz, and C. T. Yap, Redox regulation of cancer cell migration and invasion, Mitochondrion, vol.13, pp.246-53, 2013.

V. J. Thannickal and B. L. Fanburg, Reactive oxygen species in cell signaling, Am J Physiol Lung Cell Mol Physiol, vol.279, pp.1005-1033, 2000.

H. Kimura, T. Sawada, S. Oshima, K. Kozawa, T. Ishioka et al., Toxicity and roles of reactive oxygen species, Curr Drug Targets Inflamm Allergy, vol.4, pp.489-95, 2005.

K. Bedard and K. H. Krause, The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology, Physiol Rev, vol.87, pp.245-313, 2007.

J. A. Mobley and R. W. Brueggemeier, Estrogen receptor-mediated regulation of oxidative stress and DNA damage in breast cancer, Carcinogenesis, vol.25, pp.3-9, 2004.

S. Jain, D. Saxena, P. G. Kumar, S. S. Koide, and M. Laloraya, Effect of estradiol and selected antiestrogens on pro-and antioxidant pathways in mammalian uterus, Contraception, vol.60, pp.111-119, 1999.

C. Borras, J. Gambini, M. C. Gomez-cabrera, J. Sastre, F. V. Pallardo et al., 17beta-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/ NFkappaB cascade, Aging Cell, vol.4, pp.113-121, 2005.

M. Razandi, A. Pedram, V. C. Jordan, S. Fuqua, and E. R. Levin, Tamoxifen regulates cell fate through mitochondrial estrogen receptor beta in breast cancer, Oncogene, vol.32, pp.3274-85, 2013.

R. Ponzone, N. Biglia, M. E. Jacomuzzi, L. Mariani, A. Dominguez et al., Antihormones in prevention and treatment of breast cancer, Ann N Y Acad Sci, vol.1089, pp.143-58, 2006.

E. Badia, J. Oliva, P. Balaguer, and V. Cavailles, Tamoxifen resistance and epigenetic modifications in breast cancer cell lines, Curr Med Chem, vol.14, pp.3035-3080, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00230236

R. Clarke, F. Leonessa, J. N. Welch, and T. C. Skaar, Cellular and molecular pharmacology of antiestrogen action and resistance, Pharmacol Rev, vol.53, pp.25-71, 2001.

S. K. Cho, A. Pedram, E. R. Levin, and Y. J. Kwon, Acid-degradable coreshell nanoparticles for reversed tamoxifen-resistance in breast cancer by silencing manganese superoxide dismutase (MnSOD), Biomaterials, vol.34, pp.10228-10265, 2013.

E. Badia, A. Docquier, M. Busson, M. Lapierre, P. Pujol et al., Long-term treatment with the pure anti-estrogen fulvestrant durably remodels estrogen signaling in BG-1 ovarian cancer cells, J Steroid Biochem Mol Biol, vol.132, pp.692-700, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00705893

S. J. Johnston and K. L. Cheung, Fulvestrant-a novel endocrine therapy for breast cancer, Curr Med Chem, vol.17, pp.902-916, 2010.

J. D. Croxtall and K. Mckeage, Fulvestrant: a review of its use in the management of hormone receptor-positive metastatic breast cancer in postmenopausal women, Drugs, vol.71, pp.363-80, 2011.

D. Trachootham, W. Lu, M. A. Ogasawara, R. D. Nilsa, and P. Huang, Redox regulation of cell survival, Antioxid Redox Signal, vol.10, pp.1343-74, 2008.

E. Badia, M. J. Duchesne, S. Fournier-bidoz, A. E. Simar-blanchet, B. Terouanne et al., Hydroxytamoxifen induces a rapid and irreversible inactivation of an estrogenic response in an MCF-7-derived cell line, Cancer Res, vol.54, pp.5860-5866, 1994.

J. Oliva, S. El-messaoudi, F. Pellestor, M. Fuentes, V. Georget et al., Involvement of HP1alpha protein in irreversible transcriptional inactivation by antiestrogens in breast cancer cells, FEBS Lett, vol.579, pp.4278-86, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00016567

A. Rossary, K. Arab, J. Goudable, and J. P. Steghens, Re´gulation de l'activite´ des NADPH oxydases en pre´sence d'acides gras, Ann Biol Clin, vol.65, pp.33-40, 2007.

A. Juhasz, Y. Ge, S. Markel, A. Chiu, L. Matsumoto et al., Expression of NADPH oxidase homologues and accessory genes in human cancer cell lines, tumours and adjacent normal tissues, Free Radic Res, vol.43, pp.523-555, 2009.

M. B. Gariboldi, F. Terni, R. Ravizza, S. Meschini, M. Marra et al., The nitroxide Tempol modulates anthracycline resistance in breast cancer cells, Free Radic Biol Med, vol.40, pp.1409-1427, 2006.

K. Wassmann, S. Wassmann, and G. Nickenig, Progesterone antagonizes the vasoprotective effect of estrogen on antioxidant enzyme expression and function, Circ Res, vol.97, pp.1046-54, 2005.

A. H. Wagner, M. R. Schroeter, and M. Hecker, 17beta-estradiol inhibition of NADPH oxidase expression in human endothelial cells, Faseb J, vol.15, pp.2121-2151, 2001.

K. Block, Y. Gorin, D. D. New, A. Eid, T. Chelmicki et al., The NADPHoxidase subunit p22phox inhibits the function of the tumor suppressor protein tuberin, Am J Pathol, vol.176, pp.2447-55, 2010.

M. Edderkaoui, C. Nitsche, L. Zheng, S. J. Pandol, I. Gukovsky et al., NADPH oxidase activation in pancreatic cancer cells is mediated through Akt-dependent up-regulation of p22phox, J Biol Chem, vol.286, pp.7779-87, 2011.

S. E. Park, J. D. Song, K. M. Kim, Y. M. Park, N. D. Kim et al., Diphenyleneiodonium induces ROS-independent p53 expression and apoptosis in human RPE cells, FEBS Lett, vol.581, pp.180-186, 2007.

C. Riganti, C. Costamagna, A. Bosia, and D. Ghigo, The NADPH oxidase inhibitor apocynin (acetovanillone) induces oxidative stress, Toxicol Appl Pharmacol, vol.212, pp.179-87, 2006.

, Breast Cancer, vol.23, pp.692-700, 2016.